259 related articles for article (PubMed ID: 19833205)
21. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1.
Doostdar H; Burke MD; Mayer RT
Toxicology; 2000 Apr; 144(1-3):31-8. PubMed ID: 10781868
[TBL] [Abstract][Full Text] [Related]
22. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.
Zhang Y; Gaikwad NW; Olson K; Zahid M; Cavalieri EL; Rogan EG
Metabolism; 2007 Jul; 56(7):887-94. PubMed ID: 17570247
[TBL] [Abstract][Full Text] [Related]
23. Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes.
Kim HJ; Lee SB; Park SK; Kim HM; Park YI; Dong MS
Arch Pharm Res; 2005 Oct; 28(10):1114-21. PubMed ID: 16276964
[TBL] [Abstract][Full Text] [Related]
24. Preferential induction of CYP1A1 over CYP1B1 in human breast cancer MCF-7 cells after exposure to berberine.
Wen CJ; Wu LX; Fu LJ; Shen DY; Zhang X; Zhang YW; Yu J; Zhou HH
Asian Pac J Cancer Prev; 2014; 15(1):495-9. PubMed ID: 24528081
[TBL] [Abstract][Full Text] [Related]
25. The carotenoid lycopene differentially regulates phase I and II enzymes in dimethylbenz[a]anthracene-induced MCF-7 cells.
Wang H; Leung LK
Nutrition; 2010; 26(11-12):1181-7. PubMed ID: 20400267
[TBL] [Abstract][Full Text] [Related]
26. Inductive and inhibitory effects of non-ortho-substituted polychlorinated biphenyls on estrogen metabolism and human cytochromes P450 1A1 and 1B1.
Pang S; Cao JQ; Katz BH; Hayes CL; Sutter TR; Spink DC
Biochem Pharmacol; 1999 Jul; 58(1):29-38. PubMed ID: 10403516
[TBL] [Abstract][Full Text] [Related]
27. Estrogens, enzyme variants, and breast cancer: a risk model.
Crooke PS; Ritchie MD; Hachey DL; Dawling S; Roodi N; Parl FF
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1620-9. PubMed ID: 16985022
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
Chang TK; Chen J; Yang G; Yeung EY
J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in P450 CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol.
Li DN; Seidel A; Pritchard MP; Wolf CR; Friedberg T
Pharmacogenetics; 2000 Jun; 10(4):343-53. PubMed ID: 10862525
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms.
Lee AJ; Cai MX; Thomas PE; Conney AH; Zhu BT
Endocrinology; 2003 Aug; 144(8):3382-98. PubMed ID: 12865317
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
Shimada T; Guengerich FP
Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
[TBL] [Abstract][Full Text] [Related]
32. Catalytic properties of polymorphic human cytochrome P450 1B1 variants.
Shimada T; Watanabe J; Kawajiri K; Sutter TR; Guengerich FP; Gillam EM; Inoue K
Carcinogenesis; 1999 Aug; 20(8):1607-13. PubMed ID: 10426814
[TBL] [Abstract][Full Text] [Related]
33. Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.
Shimada T; Tanaka K; Takenaka S; Murayama N; Martin MV; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
Chem Res Toxicol; 2010 Dec; 23(12):1921-35. PubMed ID: 21053930
[TBL] [Abstract][Full Text] [Related]
34. CYP450- and COMT-derived estradiol metabolites inhibit activity of human coronary artery SMCs.
Dubey RK; Gillespie DG; Zacharia LC; Barchiesi F; Imthurn B; Jackson EK
Hypertension; 2003 Mar; 41(3 Pt 2):807-13. PubMed ID: 12624000
[TBL] [Abstract][Full Text] [Related]
35. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.
Hanna IH; Dawling S; Roodi N; Guengerich FP; Parl FF
Cancer Res; 2000 Jul; 60(13):3440-4. PubMed ID: 10910054
[TBL] [Abstract][Full Text] [Related]
36. Sequential action of phase I and II enzymes cytochrome p450 1B1 and glutathione S-transferase P1 in mammary estrogen metabolism.
Hachey DL; Dawling S; Roodi N; Parl FF
Cancer Res; 2003 Dec; 63(23):8492-9. PubMed ID: 14679015
[TBL] [Abstract][Full Text] [Related]
37. NADPH- and hydroperoxide-supported 17beta-estradiol hydroxylation catalyzed by a variant form (432L, 453S) of human cytochrome P450 1B1.
Spink DC; Spink BC; Zhuo X; Hussain MM; Gierthy JF; Ding X
J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):11-8. PubMed ID: 11074351
[TBL] [Abstract][Full Text] [Related]
38. Urban dust particulate matter alters PAH-induced carcinogenesis by inhibition of CYP1A1 and CYP1B1.
Courter LA; Musafia-Jeknic T; Fischer K; Bildfell R; Giovanini J; Pereira C; Baird WM
Toxicol Sci; 2007 Jan; 95(1):63-73. PubMed ID: 17060372
[TBL] [Abstract][Full Text] [Related]
39. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates the induction of DNA strand breaks and poly(ADP-ribose) polymerase-1 activation by 17beta-estradiol in human breast carcinoma cells through alteration of CYP1A1 and CYP1B1 expression.
Lin PH; Lin CH; Huang CC; Fang JP; Chuang MC
Chem Res Toxicol; 2008 Jul; 21(7):1337-47. PubMed ID: 18558727
[TBL] [Abstract][Full Text] [Related]
40. Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.
Shimada T; Murayama N; Okada K; Funae Y; Yamazaki H; Guengerich FP
Chem Res Toxicol; 2007 Mar; 20(3):489-96. PubMed ID: 17291012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]